Qingdi Q Li

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi β-Elemene Promotes Cisplatin-induced Cell Death in Human Bladder Cancer and Other Carcinomas
    Q Quentin Li
    National Institutes of Health, Bethesda, Maryland 20892, U S A E mail and Dr Yuhua Zhong, Beihai Institute of Endocrine and Metabolic Diseases, Beihai, Guangxi 536000, P R C
    Anticancer Res 33:1421-8. 2013
  2. ncbi β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells
    Baobo Zou
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Res 33:929-40. 2013
  3. ncbi Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs
    Q Quentin Li
    West Virginia University School of Medicine, Morgantown, WV 26506, USA
    Med Oncol 30:488. 2013
  4. ncbi Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells
    Qingdi Quentin Li
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Res 33:65-76. 2013
  5. ncbi β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells
    Rebecca X Lee
    Department of Microbiology, Immunology and Cell Biology, Mary Babb Randolph Cancer Center, West Virginia University School of Medicine, Morgantown, WV, USA
    Anticancer Res 32:3103-13. 2012
  6. ncbi beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis
    Qingdi Q Li
    The Mary Babb Randolph Cancer Center and Department of Microbiology, Immunology and Cell Biology, Robert C Byrd Health Sciences Center, West Virginia University of Medicine, Morgantown, WV 26506, USA
    Oncol Rep 22:161-70. 2009
  7. ncbi In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma
    Jinshun Zhao
    Mary Babb Randolph Cancer Center, Department of Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, WV 26506, USA
    Int J Oncol 31:241-52. 2007
  8. ncbi Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells
    Xiaosong Zhong
    Mary Babb Randolph Cancer Center, and Department of Microbiology, Immunology and Cell Biology, West Virginia University School of Medicine and Robert C. Byrd Health Sciences Center, Morgantown, WV 26506, USA
    Int J Oncol 25:445-51. 2004
  9. ncbi Molecular mechanism of antitumor activity of taxanes in lung cancer (Review)
    Jinshun Zhao
    The Mary Babb Randolph Cancer Center, and Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, 26506, USA
    Int J Oncol 27:247-56. 2005
  10. ncbi Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)
    Gangduo Wang
    Mary Babb Randolph Cancer Center and Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, WV 26506, USA
    Oncol Rep 12:955-65. 2004

Collaborators

  • Eddie Reed
  • Lan Huang
  • Hong Ding
  • Manchao Zhang
  • Li Li
  • Jinshun Zhao
  • Gangduo Wang
  • Baobo Zou
  • Rebecca X Lee
  • Wei Zhang
  • Christopher F Cuff
  • Kevin Gardner
  • Qiang Xiao
  • Jee Eun Kim
  • Xiping Li
  • Xiaosong Zhong
  • Jueli M Li
  • Zhong Mian Pan
  • Qi Wang
  • Bu Jian Tang
  • Su mei Wang
  • Hong Chen
  • Hsin Chih Yang
  • Zhi jun Yang
  • Junyi Xu
  • Keyi Xia
  • Ning Tan
  • Changqing Wang
  • Yubo Xie
  • Cheryl Neace
  • Yunfeng Zhu
  • Guodong Hu

Detail Information

Publications14

  1. ncbi β-Elemene Promotes Cisplatin-induced Cell Death in Human Bladder Cancer and Other Carcinomas
    Q Quentin Li
    National Institutes of Health, Bethesda, Maryland 20892, U S A E mail and Dr Yuhua Zhong, Beihai Institute of Endocrine and Metabolic Diseases, Beihai, Guangxi 536000, P R C
    Anticancer Res 33:1421-8. 2013
    ..Cisplatin combined with β-elemene as a chemosensitizer warrants further pre-clinical therapeutic studies and may be useful for the treatment of cisplatin-resistant bladder cancer and other types of carcinomas...
  2. ncbi β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells
    Baobo Zou
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Res 33:929-40. 2013
    ..This promising new therapeutic combination warrants further pre-clinical exploration for the treatment of chemoresistant ovarian cancer and other types of tumors...
  3. ncbi Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs
    Q Quentin Li
    West Virginia University School of Medicine, Morgantown, WV 26506, USA
    Med Oncol 30:488. 2013
    ....
  4. ncbi Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells
    Qingdi Quentin Li
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Res 33:65-76. 2013
    ..Overall, this study provides, to our knowledge, the first evidence showing that synthetic analogs of β-elemene hold promise for patients with brain tumors...
  5. ncbi β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells
    Rebecca X Lee
    Department of Microbiology, Immunology and Cell Biology, Mary Babb Randolph Cancer Center, West Virginia University School of Medicine, Morgantown, WV, USA
    Anticancer Res 32:3103-13. 2012
    ....
  6. ncbi beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis
    Qingdi Q Li
    The Mary Babb Randolph Cancer Center and Department of Microbiology, Immunology and Cell Biology, Robert C Byrd Health Sciences Center, West Virginia University of Medicine, Morgantown, WV 26506, USA
    Oncol Rep 22:161-70. 2009
    ..Our data provide a rationale for developing a combination of beta-elemene and cisplatin as a regimen for the treatment of lung carcinoma and other cisplatin-resistant tumors...
  7. ncbi In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma
    Jinshun Zhao
    Mary Babb Randolph Cancer Center, Department of Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, WV 26506, USA
    Int J Oncol 31:241-52. 2007
    ..Finally, the beta-elemene-induced alteration of cell membrane permeability, which has potential to result in enhanced cellular uptake of taxanes, may also contribute to the synergistic interactions of the combination treatments...
  8. ncbi Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells
    Xiaosong Zhong
    Mary Babb Randolph Cancer Center, and Department of Microbiology, Immunology and Cell Biology, West Virginia University School of Medicine and Robert C. Byrd Health Sciences Center, Morgantown, WV 26506, USA
    Int J Oncol 25:445-51. 2004
    ..Together, these results suggest that the chemosensitizing effect of SU5416 on ovarian tumor cells may be mediated, at least in part, through inhibiting G1 checkpoint control and up-regulating the apoptotic response to cisplatin...
  9. ncbi Molecular mechanism of antitumor activity of taxanes in lung cancer (Review)
    Jinshun Zhao
    The Mary Babb Randolph Cancer Center, and Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, 26506, USA
    Int J Oncol 27:247-56. 2005
    ....
  10. ncbi Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)
    Gangduo Wang
    Mary Babb Randolph Cancer Center and Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, WV 26506, USA
    Oncol Rep 12:955-65. 2004
    ....
  11. ncbi Apoptosis in prostate cancer: progressive and therapeutic implications (Review)
    Gangduo Wang
    Mary Babb Randolph Cancer Center, West Virginia University Health Sciences Center, Morgantown, WV 26506, USA
    Int J Mol Med 14:23-34. 2004
    ....
  12. ncbi Transcription factor E2F-1 is upregulated in human gastric cancer tissues and its overexpression suppresses gastric tumor cell proliferation
    Qiang Xiao
    Department of Surgery, First Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P R China
    Cell Oncol 29:335-49. 2007
    ....
  13. ncbi Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis
    Wei Zhang
    Department of Gynecologic Oncology, Cancer Hospital, Guangxi Medical University, Nanning, Guangxi 530021, P R China
    Anticancer Res 31:3423-8. 2011
    ..This study evaluated the clinical value of the combined detection of serum cathepsin L (CL), heparanase (Hpa), and matrix metalloproteinase-9 (MMP-9) for determining the degree of ovarian cancer invasion and metastasis before surgery...
  14. ncbi Demonstration of differential gene expression between sensitive and resistant ovarian tumor cells by fluorescence differential display-PCR analysis
    Li Li
    Department of Gynecologic Oncology, Cancer Institute and Hospital, Guangxi Medical University Medical Center, Nanning, Guangxi 530021, P R China
    Oncol Rep 13:793-9. 2005
    ....